Transformed non-Hodgkin lymphoma in the rituximab era: Analysis of the NCCN outcomes database

British Journal of Haematology

Volumn 163, Issue 4, 2013, Pages 487-495

  Ban Hoefen, Makiko ^a   Vanderplas, Ann ^b   Crosby Thompson, Allison L ^c   Abel, Gregory A ^c   Czuczman, Myron S ^d   Gordon, Leo I ^e   Kaminski, Mark S ^f   Kelly, Jennifer ^a   Millenson, Michael ^g   Nademanee, Auayporn P ^b   Rodriguez, Maria A ^h   Zelenetz, Andrew D ⁱ   Niland, Joyce ^b   Lacasce, Ann S ^c   Friedberg, Jonathan W ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^g FOX CHASE CANCER CENTER   (United States)

^h UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

ⁱ MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Diffuse large B cell lymphoma; Histological transformation; Non Hodgkin lymphoma; Rituximab era; Stem cell transplantation

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; LENALIDOMIDE; RITUXIMAB; VINCRISTINE;

ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BACTERIAL INFECTION; CANCER CHEMOTHERAPY; CANCER REGISTRY; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HISTOLOGY; HUMAN; LIVER VENOOCCLUSIVE DISEASE; LYMPHOCYTOMA; MAJOR CLINICAL STUDY; MALE; MARGINAL ZONE LYMPHOMA; MORTALITY; MYCOSIS; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOIMMUNOTHERAPY; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME;

DIFFUSE LARGE B-CELL LYMPHOMA; HISTOLOGICAL TRANSFORMATION; NON-HODGKIN LYMPHOMA; RITUXIMAB ERA; STEM-CELL TRANSPLANTATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; CELL TRANSFORMATION, NEOPLASTIC; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84886416184     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12570     Document Type: Article

References (36)

1. Al-Tourah, A.J., Savage, K.J., Gill, K.K., Klasa, R.J., Sehn, L.H., Shenkier, T.N., Gascoyne, R.D. & Connors, J.M. (2007) Addition of rituximab to CHOP chemotherapy significantly improves survival of patients with transformed lymphoma. Blood (ASH Annual Meeting Abstracts), 110, 790.
2. Al-Tourah, A.J., Gill, K.K., Chhanabhai, M., Hoskins, P.J., Klasa, R.J., Savage, K.J., Sehn, L.H., Shenkier, T.N., Gascoyne, R.D. & Connors, J.M. (2008) Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma. Journal of Clinical Oncology, 26, 5165-5169.
3. Andreadis, C., Schuster, S.J., Chong, E.A., Svoboda, J., Luger, S.M., Porter, D.L., Tsai, D.E., Nasta, S.D., Elstrom, R.L., Goldstein, S.C., Downs, L.H., Mangan, P.A., Cunningham, K.A., Hummel, K.A., Gimotty, P.A., Siegel, D.L., Glatstein, E. & Stadtmauer, E.A. (2005) Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma. Bone Marrow Transplantation, 36, 955-961.
4. Bains, P., Al-Tourah, A., Campbell, B.A., Pickles, T., Gascoyne, R.D., Connors, J.M. & Savage, K.J. (2013) Incidence of transformation to aggressive lymphoma in limited-stage follicular lymphoma treated with radiotherapy. Annals of Oncology, 24, 428-432.
5. Bastion, Y., Sebban, C., Berger, F., Felman, P., Salles, G., Dumontet, C., Bryon, P.A. & Coiffier, B. (1997) Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients. Journal of Clinical Oncology, 15, 1587-1594.
6. Bernstein, S.H. & Burack, W.R. (2009) The incidence, natural history, biology, and treatment of transformed lymphomas. Hematology Am Soc Hematol Educ Program, 2009, 532-541.
7. Carlotti, E., Wrench, D., Matthews, J., Iqbal, S., Davies, A., Norton, A., Hart, J., Lai, R., Montoto, S., Gribben, J.G., Lister, T.A. & Fitzgibbon, J. (2009) Transformation of Follicular Lymphoma to Diffuse Large B Cell Lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the Follicular Lymphoma clone. Blood, 113, 3553-3557.
8. Chen, C.I., Crump, M., Tsang, R., Stewart, A.K. & Keating, A. (2001) Autotransplants for histologically transformed follicular non-Hodgkin's lymphoma. British Journal of Haematology, 113, 202-208.
9. Czuczman, M.S., Vose, J.M., Witzig, T.E., Zinzani, P.L., Buckstein, R., Polikoff, J., Li, J., Pietronigro, D., Ervin-Haynes, A. & Reeder, C.B. (2011) The differential effect of lenalidomide monotherapy in patients with relapsed or refractory transformed non-Hodgkin lymphoma of distinct histological origin. British Journal of Haematology, 154, 477-481.
10. Davies, A.J., Rosenwald, A., Wright, G., Lee, A., Last, K.W., Weisenburger, D.D., Chan, W.C., Delabie, J., Braziel, R.M., Campo, E., Gascoyne, R.D., Jaffe, E.S., Muller-Hermelink, K., Ott, G., Calaminici, M., Norton, A.J., Goff, L.K., Fitzgibbon, J., Staudt, L.M. & Lister, A.T. (2007) Transformation of follicular lymphoma to diffuse large B cell lymphoma proceeds by distinct oncogenic mechanisms. British Journal of Haematology, 136, 286-293.
11. Doocey, R.T., Toze, C.L., Connors, J.M., Nevill, T.J., Gascoyne, R.D., Barnett, M.J., Forrest, D.L., Hogge, D.E., Lavoie, J.C., Nantel, S.H., Shepherd, J.D., Sutherland, H.J., Voss, N.J., Smith, C.A. & Song, K.W. (2005) Allogeneic hematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphoma. British Journal of Haematology, 131, 223-230.
12. Eide, M.B., Lauritzsen, G.F., Kvalheim, G., Kolstad, A., Fagerli, U.M., Maisenholder, M., Ostenstad, B., Fluge, O., Delabie, J., Aarset, H., Liestol, K. & Holte, H. (2011) High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study. British Journal of Haematology, 152, 600-610.
13. Fisher, R.I., LeBlanc, M., Press, O.W., Maloney, D.G., Unger, J.M. & Miller, T.P. (2005a) New treatment options have changed the survival of patients with follicular lymphoma. Journal of Clinical Oncology, 23, 8447-8452.
14. Fisher, R.I., Kaminski, M.S., Wahl, R.L., Knox, S.J., Zelenetz, A.D., Vose, J.M., Leonard, J.P., Kroll, S., Goldsmith, S.J. & Coleman, M. (2005b) Tositumomab and iodine-131 tositumomab produces durable complete remissions in a subset of heavily pretreated patients with low-grade and transformed non-Hodgkin's lymphomas. Journal of Clinical Oncology, 23, 7565-7573.
15. Foran, J.M., Apostolidis, J., Papamichael, D., Norton, A.J., Matthews, J., Amess, J.A., Lister, T.A. & Rohatiner, A.Z. (1998) High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: a study of 27 patients from a single centre. Annals of Oncology, 9, 865-964.
16. Friedberg, J. (2012) Double hit diffuse large B cell lymphoma. Journal of Clinical Oncology, 30, 3439-3443.
17. Friedberg, J.W., Neuberg, D., Gribben, J.G., Mauch, P., Anderson, K.C., Soiffer, R.J., Takvorian, T., Fisher, D.C., Schlossman, R., Jallow, H., Kuhlman, C., Ritz, J. & Freedman, A.S. (1999) Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies. Biology of Blood and Bone Marrow Transplantation, 5, 262-268.
18. Gisselbrecht, C., Glass, B., Mounier, N., Singh, G.D., Linch, D.C., Trneny, M., Bosly, A., Ketterer, N., Shpilberg, O., Hagberg, H., Ma, D., Briere, J., Moskowitz, C.H. & Schmitz, N. (2010) Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era. Journal of Clinical Oncology, 28, 4184-4190.
19. Glas, A.M., Knoops, L., Delahaye, L., Kersten, M.J., Kibbelaar, R.E., Wessels, L.A., van Laar, R., van Krieken, J.H., Baars, J.W., Raemaekers, J., Kluin, P.M. & van't Veer, L.J. & de John, D. (2007) Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of Follicular Lymphoma. Journal of Clinical Oncology, 25, 390-398.
20. Gordon, L.I., Witzig, T., Molina, A., Czuczman, M., Emmanouilides, C., Joyce, R., Vo, K., Theuer, C., Pohlman, B., Bartlett, N., Wiseman, G., Darif, M. & White, C. (2004) Yttrium 90-labeled ibritumomab tiuxetan radioimmunotherapy produces high response rates and durable remissions in patients with previously treated B-cell lymphoma. Clinical Lymphoma, 5, 98-101.
21. LaCasce, A.S., Kho, M.E., Friedberg, J.W., Niland, J.C., Abel, G.A., Rodriguez, M.A., Czuczman, M.S., Millenson, M.M., Zelenetz, A.D. & Weeks, J.C. (2008) Comparison of Referring and Final Pathology for Patients with Non-Hodgkin's Lymphoma in the National Comprehensive Cancer Network. Journal of Clinical Oncology, 26, 5107-5112.
22. Lawrie, C.H., Chi, J., Taylor, S., Tramonti, D., Ballabio, E., Palazzo, S., Saunders, N.J., Pezzella, F., Boultwood, J., Wainscoat, J.S. & Hatton, C.S. (2009) Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma. Journal of Cellular and Molecular Medicine, 13, 1248-1260.
23. Link, B.K., Maurer, M.J., Nowakowski, G.S., Ansell, S.M., Macon, W.R., Syrbu, S.I., Slager, S.L., Thompson, C.A., Inwards, D.J., Johnston, P.B., Colgan, J.P., Witzig, T.E., Habermann, T.M. & Cerhan, J.R. (2012) Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology Resource. Journal of Clinical Oncology, 26, 3272-3278.
24. Martinez-Climent, J.A., Alizadeh, A.A., Segraves, R., Blesa, D., Rubio-Moscardo, F., Albertson, D.G., Garcia-Conde, J., Dyer, M.J., Levy, R., Pinkel, D. & Lossos, I.S. (2003) Transformation of follicular lymphoma to diffuse large B cell lymphoma is associated with heterogeneous set of DNA copy number and gene expression alterations. Blood, 101, 3109-3117.
25. Montoto, S., Davies, A.J., Matthews, J., Calaminici, M., Norton, A.J., Amess, J., Vinnicombe, S., Waters, R., Rohatiner, A.Z. & Lister, T.A. (2007) Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma. Journal of Clinical Oncology, 25, 2426-2433.
26. Ramadan, K.M., Connors, J.M. & Al-Tourah, A. (2008) Autologous stem cell transplantation is superior to myeloablative allogeneic SCT as a salvage therapy for patients with refractory/relapsed transformed lymphoma [abstract]. Blood, 112, 4459.
27. Reddy, N., Oluwole, O., Greer, J.P., Goodman, S., Engelhardt, B., Jagasia, M.H. & Savani, B.N. (2012) Superior long-term outcome of patients with early transformation of non-Hodgkin lymphoma undergoing stem cell transplantation. Clinical Lymphoma, Myeloma, and Leukemia, 12, 406-411.
28. Rezvani, A.R., Storer, B., Maris, M., Sorror, M.L., Agura, E., Maziarz, R.T., Wade, J.C., Chauncey, T., Forman, S.J., Lange, T., Shizuru, J., Langston, A., Pulsipher, M.A., Sandmaier, B.M., Storb, R. & Maloney, D.G. (2008) Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma. Journal of Clinical Oncology, 26, 211-217.
29. Rossi, D., Berra, E., Cerri, M., Deambrogi, C., Barbieri, C., Franceschetti, S., Lunghi, M., Conconi, A., Paulli, M., Matolcsy, A., Pasqualucci, L., Capello, D. & Gaidano, G. (2006) Aberrant somatic hypermutation in transformation of follicular lymphoma and CLL to diffuse large B cell lymphoma. Haematologica, 91, 1405-1409.
30. Sabloff, M., Atkins, H.L., Bence-Bruckler, I., Bredeson, C., Fergusson, D., Genest, P., Hopkins, H., Hutton, B., Mcdiarmid, S. & Huebsch, L.B. (2007) A 15-year analysis of early and late autologous hematopoietic stem cell transplant in relapsed, aggressive, transformed, and nontransformed follicular lymphoma. Biology of Blood and Marrow Transplantation, 13, 956-964.
31. Swenson, W.T., Wooldridge, J.E., Lynch, C.F., Forman-Hoffman, V.L., Chrischilles, E. & Link, B.K. (2005) Improved survival of follicular lymphoma patients in the United States. Journal of Clinical Oncology, 23, 5019-5026.
32. Thomson, K.J., Morris, E.C., Bloor, A., Cook, G., Milligan, D., Parker, A., Clark, F., Yung, L., Linch, D.C., Chakraverty, R., Peggs, K.S. & Mackinnon, S. (2009) Favorable long-term survival after reduced-intensity allogeneic transplantation for multiple-relapse aggressive non-Hodgkin's lymphoma. Journal of Clinical Oncology, 27, 426-432.
33. Villa, D., Crump, M., Panzarella, T., Savage, K.J., Toze, C.L., Stewart, D.A., MacDonald, D.A., Buckstein, R., Lee, C., Alzahrani, M., Rubinger, M., Foley, R., Xenocostas, A., Sabloff, M., Muccilli, Al., Chua, N., Couture, F., Larouche, J.F., Cohen, S., Connors, J.M., Ambler, K., Al-Tourah, A., Ramadan, K.M. & Kuruvilla, J. (2013) Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: a report of the Canadian blood and marrow transplant group. Journal of Clinical Oncology, 31, 1-9.
34. Williams, C.D., Harrison, C.N., Lister, T.A., Norton, A.J., Blystad, A.K., Coiffier, B., Taghipour, G., Schmitz, N. & Goldstone, A.H. (2001) High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: a case-matched study from the European Bone Marrow Transplant Registry. Journal of Clinical Oncology, 19, 727-735.
35. Wondergem, M.J., Zijlstra, J.M., de Rooij, M., Visser, O.J., Huijgens, P.C. & Zweegman, S. (2012) Improving survival in patients with transformed B cell non Hodgkin lymphoma: consolidation with 90Yttrium ibritumomab tiuxetan-BEAM and autologous stem cell transplantation. British Journal of Haematology, 157, 395-397.
36. Yuen, A.R., Kamel, O.W., Halpern, J. & Horning, S.J. (1995) Long-term survival after histologic transformation of low-grade follicular lymphoma. Journal of Clinical Oncology, 13, 1726-1733.